NCT05456165 2024-12-31
Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
Gritstone bio, Inc.
Phase 2 Withdrawn
Gritstone bio, Inc.
Nanchong Central Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute
University of California, San Francisco